Teva Wins $176M From Eli Lilly In Migraine Drug Patent Trial
By Brian Dowling ( November 9, 2022, 6:59 PM EST) -- A Boston federal jury on Wednesday ordered Eli Lilly & Co. to pay $176.5 million to Teva Pharmaceuticals after finding that its migraine drug Emgality willfully infringed three Teva patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.